Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines

Mary Josephine P Pilat, Eric D. Schwab, Kai Ling Yao, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

Molecular changes in the progressive state of tumorigenesis often include altered patterns of DNA methylation. Utilizing a series of breast epithelial cell lines, the overall 5-methylcytosine content in genomic DNA demonstrated an overall decrease when comparing two malignant cell lines (MCF-7 and T47D) with a mortal cell line (MCF 1 2M) and several derivative cell lines of the immortalized MCF10 cultures (MCF10A, -2A, -5A, AlneoT2, and 139B6). Further investigation on the methylation status of these cells lines indicated no difference in DNA methyltransferase activity, both at a protein and mRNA levels, in the nontumorigenic cell lines examined while activity was 3-10 fold higher in the tumorigenic lines (MCF7, T47D, SkBr3 MB-MDA-231, -468). Examination of the CpG island in the 5' promoter region of the estrogen receptor gene indicates that this region is unmethylated in the mortal and immortal nontumorigenic lines as well as the tumorigenic lines examined, with the exception of the estrogen receptor negative breast cell line MB-MDA-468 which appeals to be partially methylated at this site. These results indicate methylation of this CpG island does not account for the inactivation of the estrogen receptor gene in immortalized nontumorigenic breast cells, suggesting another mechanism of transcriptional inactivation of ER in this environment.

Original languageEnglish (US)
Pages (from-to)2575-2582
Number of pages8
JournalAnticancer Research
Volume18
Issue number4 A
StatePublished - Jul 1998
Externally publishedYes

Fingerprint

DNA Methylation
Breast
Epithelial Cells
Cell Line
Estrogen Receptors
CpG Islands
Methylation
5-Methylcytosine
DNA
Methyltransferases
Genetic Promoter Regions
Genes
Carcinogenesis
Messenger RNA
Proteins

Keywords

  • 5-Methylcytosine
  • CpG islands
  • Estrogen receptor
  • MCF 10

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines. / Pilat, Mary Josephine P; Schwab, Eric D.; Yao, Kai Ling; Pienta, Kenneth.

In: Anticancer Research, Vol. 18, No. 4 A, 07.1998, p. 2575-2582.

Research output: Contribution to journalArticle

Pilat, Mary Josephine P ; Schwab, Eric D. ; Yao, Kai Ling ; Pienta, Kenneth. / Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines. In: Anticancer Research. 1998 ; Vol. 18, No. 4 A. pp. 2575-2582.
@article{6fd2939f17524cbc9bf650f0aea139e5,
title = "Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines",
abstract = "Molecular changes in the progressive state of tumorigenesis often include altered patterns of DNA methylation. Utilizing a series of breast epithelial cell lines, the overall 5-methylcytosine content in genomic DNA demonstrated an overall decrease when comparing two malignant cell lines (MCF-7 and T47D) with a mortal cell line (MCF 1 2M) and several derivative cell lines of the immortalized MCF10 cultures (MCF10A, -2A, -5A, AlneoT2, and 139B6). Further investigation on the methylation status of these cells lines indicated no difference in DNA methyltransferase activity, both at a protein and mRNA levels, in the nontumorigenic cell lines examined while activity was 3-10 fold higher in the tumorigenic lines (MCF7, T47D, SkBr3 MB-MDA-231, -468). Examination of the CpG island in the 5' promoter region of the estrogen receptor gene indicates that this region is unmethylated in the mortal and immortal nontumorigenic lines as well as the tumorigenic lines examined, with the exception of the estrogen receptor negative breast cell line MB-MDA-468 which appeals to be partially methylated at this site. These results indicate methylation of this CpG island does not account for the inactivation of the estrogen receptor gene in immortalized nontumorigenic breast cells, suggesting another mechanism of transcriptional inactivation of ER in this environment.",
keywords = "5-Methylcytosine, CpG islands, Estrogen receptor, MCF 10",
author = "Pilat, {Mary Josephine P} and Schwab, {Eric D.} and Yao, {Kai Ling} and Kenneth Pienta",
year = "1998",
month = "7",
language = "English (US)",
volume = "18",
pages = "2575--2582",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 A",

}

TY - JOUR

T1 - Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines

AU - Pilat, Mary Josephine P

AU - Schwab, Eric D.

AU - Yao, Kai Ling

AU - Pienta, Kenneth

PY - 1998/7

Y1 - 1998/7

N2 - Molecular changes in the progressive state of tumorigenesis often include altered patterns of DNA methylation. Utilizing a series of breast epithelial cell lines, the overall 5-methylcytosine content in genomic DNA demonstrated an overall decrease when comparing two malignant cell lines (MCF-7 and T47D) with a mortal cell line (MCF 1 2M) and several derivative cell lines of the immortalized MCF10 cultures (MCF10A, -2A, -5A, AlneoT2, and 139B6). Further investigation on the methylation status of these cells lines indicated no difference in DNA methyltransferase activity, both at a protein and mRNA levels, in the nontumorigenic cell lines examined while activity was 3-10 fold higher in the tumorigenic lines (MCF7, T47D, SkBr3 MB-MDA-231, -468). Examination of the CpG island in the 5' promoter region of the estrogen receptor gene indicates that this region is unmethylated in the mortal and immortal nontumorigenic lines as well as the tumorigenic lines examined, with the exception of the estrogen receptor negative breast cell line MB-MDA-468 which appeals to be partially methylated at this site. These results indicate methylation of this CpG island does not account for the inactivation of the estrogen receptor gene in immortalized nontumorigenic breast cells, suggesting another mechanism of transcriptional inactivation of ER in this environment.

AB - Molecular changes in the progressive state of tumorigenesis often include altered patterns of DNA methylation. Utilizing a series of breast epithelial cell lines, the overall 5-methylcytosine content in genomic DNA demonstrated an overall decrease when comparing two malignant cell lines (MCF-7 and T47D) with a mortal cell line (MCF 1 2M) and several derivative cell lines of the immortalized MCF10 cultures (MCF10A, -2A, -5A, AlneoT2, and 139B6). Further investigation on the methylation status of these cells lines indicated no difference in DNA methyltransferase activity, both at a protein and mRNA levels, in the nontumorigenic cell lines examined while activity was 3-10 fold higher in the tumorigenic lines (MCF7, T47D, SkBr3 MB-MDA-231, -468). Examination of the CpG island in the 5' promoter region of the estrogen receptor gene indicates that this region is unmethylated in the mortal and immortal nontumorigenic lines as well as the tumorigenic lines examined, with the exception of the estrogen receptor negative breast cell line MB-MDA-468 which appeals to be partially methylated at this site. These results indicate methylation of this CpG island does not account for the inactivation of the estrogen receptor gene in immortalized nontumorigenic breast cells, suggesting another mechanism of transcriptional inactivation of ER in this environment.

KW - 5-Methylcytosine

KW - CpG islands

KW - Estrogen receptor

KW - MCF 10

UR - http://www.scopus.com/inward/record.url?scp=0031810690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031810690&partnerID=8YFLogxK

M3 - Article

C2 - 9703912

AN - SCOPUS:0031810690

VL - 18

SP - 2575

EP - 2582

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 A

ER -